This rare cancer-type is characterised by a near ubiquitous translocation resulting in a fusion protein of TAZ-CAMTA1 present in the vast majority (>90%) of patients [98], with an additional, less frequent YAP-TFE3 fusion protein also observed in a subpopulation of those diagnosed with EHE [99,100]. The gene discussed is YAP1; the disease is cancer.